Last reviewed · How we verify
NCT03200639
Cachexia in Gynecological Cancer and the Preventive Role of Weight Training
NA trial testing Combined training in Breast Cancer Female in 38 participants. Completed in 10 December 2015.
1 December 2015
Quick facts
| Lead sponsor | Universidade Federal do Triangulo Mineiro |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 38 |
| Start date | 30 May 2015 |
| Primary completion | 1 December 2015 |
| Estimated completion | 10 December 2015 |
Drugs / interventions tested
- Combined training
- High intensity interval training with body weight
Conditions studied
- Breast Cancer Female — all drugs for Breast Cancer Female →
- Gynecologic Cancer — all drugs for Gynecologic Cancer →
- Menopause — all drugs for Menopause →
- Physical Activity — all drugs for Physical Activity →
Sponsor
Universidade Federal do Triangulo Mineiro
Who can join
50 and older, female only, with Breast Cancer Female or Gynecologic Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aim was to compare the effectiveness of combined training (CT; aerobic + resistance exercises) and high-intensity interval body weight training (HIITBW) on body composition, metabolic and inflammatory profile, physical function and quality of life in older women with gynecological and breast cancer and their pair-matched controls (older women with no cancer). The hypothesis of the present clinical trial is that HIITBW is effective as well as CT for improvements on body composition, metabolic and inflammatory profile, physical function and quality of life in older women with gynecological and breast cancer.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
High-intensity body weight training is comparable to combined training in changes in muscle mass, physical performance, inflammatory markers and metabolic health in postmenopausal women at high risk for type 2 diabetes mellitus: A randomized controlled clinical trial.
Martins FM, de Paula Souza A, Nunes PRP, Michelin MA, et al · · 2018 · cited 33× · PMID 29471132 · DOI 10.1016/j.exger.2018.02.016 -
Comparative effects of high-intensity interval training with combined training on physical function markers in obese postmenopausal women: a randomized controlled trial.
Nunes PRP, Martins FM, Souza AP, Carneiro MAS, et al · · 2019 · cited 14× · PMID 31479035 · DOI 10.1097/gme.0000000000001399 -
Functional high-intensity interval training is not equivalent when compared to combined training for blood pressure improvements in postmenopausal women: a randomized controlled trial.
Nunes PRP, Silva TRGB, Carneiro MAS, Martins FM, et al · · 2022 · cited 5× · PMID 34749549 · DOI 10.1080/10641963.2021.2001481 -
Body Mass Index, waist circumference or sagittal abdominal diameter: Which parameter is better correlated with body fat changes in postmenopausal women after combined training protocol?
Limirio LS, Rossato LT, Barbosa CD, Teixeira KRC, et al · · 2020 · cited 1× · PMID 32690157 · DOI 10.1016/j.clnesp.2020.05.004
Verify or expand the search:
- PubMed search for NCT03200639
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Combined training
Trials testing the same drug.
- NCT06921564 — Effects of Combined Training on Physical Performance in Young Soccer Players · NA · completed
- NCT06746649 — Time-specific Exercise in Circadian Context · NA · active not recruiting
- NCT05136027 — TReAtment With CombinedExercise in Patients With Resistant Major Depression · NA · unknown
- NCT04937231 — Comparative Effects of Aerobic Exercises, Resistance Training and Combined Training on Heart Failure Patients · NA · completed
- NCT03314168 — Adaptations to Breast Cancer and Exercise · NA · unknown
Other recruiting trials for Breast Cancer Female
Currently open trials in the same condition.
- NCT07505797 — ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) · recruiting
- NCT07198724 — ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrin · Phase 1, PHASE2 · recruiting
- NCT07331506 — Validation of the Oncoliq Test for the Early Detection of Breast Cancer. · recruiting
- NCT07214883 — UCF MammoChat: Image Repository · recruiting
- NCT07120100 — Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Surviv · NA · recruiting
Other Universidade Federal do Triangulo Mineiro trials
Trials by the same sponsor.
- NCT07497659 — Ischemic Preconditioning in Resistance Exercise in Older Women · NA · completed
- NCT06195462 — Effects of Laying on of Hands in Fibromyalgia · NA · unknown
- NCT04152109 — Integrative and Complementary Health Practices (PICS) · NA · recruiting
- NCT03619070 — Fatigability and Physical Performance: Effects of Resistance Training Variables Manipulation · NA · unknown
- NCT03644329 — Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors. · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03200639 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Federal do Triangulo Mineiro
- Last refreshed: 27 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03200639.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing